These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3931098)

  • 1. Inhibition of platelet aggregation and thromboxane production by pinacidil.
    Goodman RP; Little DM; Wright JT
    Prostaglandins Leukot Med; 1985 Aug; 19(2):115-22. PubMed ID: 3931098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arachidonic acid induced platelet aggregation and thromboxane formation is inhibited by OKY-1581.
    Uotila P; Matintalo M; Dahl ML
    Prostaglandins Leukot Med; 1983 Nov; 12(3):299-303. PubMed ID: 6419237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium stimulates thromboxane B2 formation in human platelets.
    Imandt L; Tijhuis D; Wessels H; Haanen C; van den Berg R; Thomas C
    Prostaglandins Med; 1981 Nov; 7(5):421-9. PubMed ID: 6798588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic inhibition of thromboxane synthetase and platelet aggregation: modulatory role of cyclooxygenase products.
    Bertelé V; Falanga A; Tomasiak M; Chiabrando C; Cerletti C; de Gaetano G
    Blood; 1984 Jun; 63(6):1460-6. PubMed ID: 6426554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformations of exogenous arachidonic acid in human platelets in the presence of oleic- and eicosapentaenoic acids.
    Srivastava KC
    Prostaglandins Leukot Med; 1985 Apr; 18(1):31-7. PubMed ID: 2987977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of thromboxane synthetase inhibition on arachidonate metabolism and platelet behaviour.
    Parry MJ
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):23S-29S. PubMed ID: 6401997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of thromboxane B2 in incubates of dog platelet-rich plasma with arachidonic acid and its inhibition by different drugs.
    Chignard M; Vargaftig BB; Sors H; Dray F
    Biochem Biophys Res Commun; 1978 Dec; 85(4):1631-9. PubMed ID: 743319
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolism of arachidonic acid by macaque platelets. Implications for studies on atherosclerosis.
    Beatty CH; Howard CF; Hoskins MK; Herrington PT
    Atherosclerosis; 1985 Apr; 55(1):1-13. PubMed ID: 3924062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro effects of synthetic antioxidants and vitamin E on arachidonic acid metabolism and thromboxane formation in human platelets and on platelet aggregation.
    Agradi E; Petroni A; Socini A; Galli C
    Prostaglandins; 1981 Aug; 22(2):255-66. PubMed ID: 6794104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory action of soluble elastin on thromboxane B2 formation in blood platelets.
    Sekiya K; Okuda H
    Biochim Biophys Acta; 1984 Mar; 797(3):348-53. PubMed ID: 6320905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theophylline inhibits platelet aggregation, prostaglandin and thromboxane production by a mechanism which is independent of cyclic AMP.
    Burns GB; Dodge JA
    Agents Actions; 1984 Jan; 14(1):102-8. PubMed ID: 6322546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin F2 alpha antagonizes thromboxane A2-induced human platelet aggregation.
    Hung SC; Ghali NI; Venton DL; Le Breton GC
    Prostaglandins; 1982 Aug; 24(2):195-206. PubMed ID: 6293001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vinca alkaloids inhibit conversion of arachidonic acid to thromboxane by human platelet microsomes: comparison with other microtubule-active drugs.
    Maguire MH; Csonka-Khalifah L
    Biochim Biophys Acta; 1987 Oct; 921(3):426-36. PubMed ID: 3117116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of hydralazine on arachidonic acid metabolism in isolated, washed human platelets.
    Luderer JR; Demers LM; Janson RW; Nomides CT; Hayes AH
    Res Commun Chem Pathol Pharmacol; 1980 Apr; 28(1):43-52. PubMed ID: 7394316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP; Maguire MH
    Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cetiedil on platelet aggregation and thromboxane synthesis.
    Yamaguchi A; Asakura T; Tanoue K; Yamazaki H
    Thromb Res; 1985 Feb; 37(3):391-400. PubMed ID: 2986312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the inhibitory effects of melatonin and indomethacin on platelet aggregation and thromboxane release.
    Leach CM; Thorburn GD
    Prostaglandins; 1980 Jul; 20(1):51-6. PubMed ID: 7403573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors.
    Rajtar G; Cerletti C; Castagnoli MN; Bertelé V; de Gaetano G
    Biochem Pharmacol; 1985 Feb; 34(3):307-10. PubMed ID: 3918536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of L-histidine in vivo on human platelet function and arachidonic acid metabolism.
    Steinhauer HB; Kluthe R; Lubrich I; Schollmeyer P
    Prostaglandins Leukot Med; 1985 May; 18(2):245-54. PubMed ID: 3925464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.